CCLDHealthcare · Health Information ServicesThe 2 Wall Street analysts covering CareCloud, Inc. hold a median 12-month price target of $8 — +352.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 69 of 100 as at 14 Oct 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores CareCloud, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (99): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Issuance (12): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on CCLD, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +352.0% from it.
Of the 18 most recent actions, 2 moved their price target up and 2 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 12 Mar 2026 | Roth Capital | Maintains | Neutral | $3.25 |
| 6 Nov 2025 | Roth Capital | Maintains | Neutral | $2.25 → $3.25 |
| 14 Mar 2025 | Roth Capital | Reiterates | Neutral | $3.50 → $1.50 |
| 14 Mar 2025 | Roth MKM | Reiterates | Neutral | — |
| 14 Mar 2025 | Roth MKM | Reiterates | Neutral | $3.50 → $1.50 |
| 15 Nov 2024 | Benchmark | Reiterates | Buy | — |
| 27 Aug 2024 | Benchmark | Maintains | Buy | $4.00 → $4.50 |
| 16 May 2024 | Benchmark | Maintains | Buy | — |
| 25 Mar 2024 | Benchmark | Reiterates | Buy | — |
| 22 Mar 2024 | Maxim Group | Upgrade | Buy | — |
| 16 Nov 2023 | Benchmark | Reiterates | Buy | — |
| 4 Aug 2023 | Roth MKM | Downgrade | Neutral | — |
| 5 May 2023 | EF Hutton | Reiterates | Buy | — |
| 20 Mar 2023 | EF Hutton | Initiates | Buy | — |
| 3 Mar 2023 | HC Wainwright & Co. | Reiterates | Buy | — |
| 13 Dec 2022 | Maxim Group | Maintains | Buy | — |
| 15 Mar 2022 | B. Riley Securities | Maintains | Buy | — |
| 11 June 2021 | Cantor Fitzgerald | Initiates | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CCLD appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 14 Oct 2026, CareCloud, Inc. returned −45.2% against +17.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 25% of US stocks
Cheaper than 78% of US stocks
Cheaper than 22% of US stocks
Cheaper than 44% of US stocks
Higher than 64% of US stocks
Higher than 8% of US stocks
Higher than 56% of US stocks
Higher than 56% of US stocks
Higher than 63% of US stocks
Higher than 83% of US stocks
Higher than 84% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
CareCloud, Inc. has a market value of $82.9M and an enterprise value of $123.5M.
Revenue in the twelve months to 30 June 2026: $128.6M. The latest quarter grew 16.4% year on year.
Net income over the same four quarters: $8.0M, a 6.2% net margin.
Free cash flow in the twelve months to 30 June 2026: $19.6M, after $3.2M of capital spending.
CareCloud, Inc. spent $9.4M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 30.4×; forward P/E: 4.0× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
CareCloud, Inc. employs 3,650 people — $35K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own CareCloud, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
CareCloud said it will release its third-quarter 2026 financial results before the market opens on November 5, 2026. The company will hold a conference call at 8:30 a.m. Eastern Time that day to discuss the results.
Why it matters — CCLD watchers can note the scheduled date and time for the company’s quarterly results and discussion.
CareCloud, Inc. announced that its Board of Directors has promoted Bonnie Boyer, MBA, CPA, from Assistant Chief Financial Officer to Chief Financial Officer, effective October 1, 2026. Norman Roth will transition from Interim CFO to Advisor to the CEO as the company scales its profitable, AI-powered healthcare technology platform.
Why it matters — The appointment of a new CFO signals leadership stability and continuity as CareCloud continues to scale its AI-powered healthcare technology platform.
CareCloud confirmed with federal regulators that hackers stole the personal information and medical records of more than 3.75 million people in a data breach, making it the fifth-largest theft of health data in 2026 so far. This marks the first confirmation of the scale of the breach.
Why it matters — A breach affecting over 3.75 million patients could raise regulatory, legal, and reputational concerns for CareCloud and its stakeholders.
KabaFusion has selected CareCloud to build a first-of-its-kind, fully integrated platform for home infusion and specialty pharmacy, powered by artificial intelligence and designed for the home infusion workflow.
Why it matters — This partnership highlights CareCloud's expansion into a new healthcare segment with an AI-driven platform, potentially broadening its market reach for investors watching the company.
Seeking Alpha published the transcript of CareCloud, Inc.'s (CCLD) Q2 2026 earnings call. The excerpt contains only the headline and source, with no additional detail from the call itself.
Why it matters — A CCLD watcher would care that the company's Q2 2026 earnings-call transcript is now available for review.
The 2 Wall Street analysts covering CareCloud, Inc. have a median 12-month price target of $8, with estimates ranging from $6 to $8. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 2 analysts covering CareCloud, Inc., 2 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks CareCloud, Inc. 69 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 14 Oct 2026, CareCloud, Inc. ranks 69 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (99 of 100).
No one can know that. What the data says: the median 12-month target from 2 analysts implies +352.0% from the last close, and Ticker Nerd's factor model ranks CareCloud, Inc. 69 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering CareCloud, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CCLD are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $6 to $8 over the next 12 months.
CareCloud, Inc. returned -45.2% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
CareCloud Inc. is a healthcare information technology company that provides cloud-based software and related services for medical practices, health systems, and hospitals.
The most recent item we track (GlobeNewsWire, 15 Oct 2026): "CareCloud to Announce Third Quarter 2026 Results on November 5, 2026". CareCloud said it will release its third-quarter 2026 financial results before the market opens on November 5, 2026. The company will hold a conference call at 8:30 a.m. Eastern Time that day to discuss the results.
CareCloud Inc. is a healthcare information technology company that provides cloud-based software and related services for medical practices, health systems, and hospitals. Its core offerings center on revenue cycle management, practice management, electronic health records, telehealth, patient experience management, and business intelligence, helping healthcare organizations coordinate clinical, financial, and administrative workflows. The company also offers complementary professional services, including implementation support, consulting, and staffing solutions, with products designed to improve operational efficiency and simplify day-to-day practice operations. CareCloud serves providers across the United States through a SaaS-based platform built for a range of specialties and care settings. Headquartered in Somerset, New Jersey, CareCloud focuses on technology-enabled tools that support modern healthcare delivery and back-office management.
CEO Mr. A. Hadi Chaudhry · 3,650 employees · United States · https://www.carecloud.com
